The Village with Sputum-Positive Coughs
A hill district reports 14 new sputum-positive tuberculosis cases in one ward of 4,000 people over 6 months, up from 3 in the previous 6 months. Most are adults aged 20–45; two are children under 5 living in the same household as an adult case. The district hospital has microscopy, a GeneXpert machine with limited cartridges, and a DOTS program. A community health volunteer reports that many patients stop treatment after 2 months when they feel better, and that several households share cramped rooms with a single ventilated window. The district health officer asks you to advise on the response.
1. Is this an outbreak? What data would you use to decide, and what does the clustering suggest?
Read the worked answer
Treat it as a suspected outbreak/cluster until disproven.
Data to assemble:
- Baseline incidence for the ward and district over previous years, not just the prior 6 months - 14 vs 3 may partly reflect improved case finding.
- Case definition and confirmation: smear/Xpert-positive vs clinically diagnosed; verify that all 14 are true cases and not duplicates.
- Person, place, time: map households, look for shared spaces (school, workplace, tea shop), and check for a common source.
- Drug-susceptibility results - a cluster of resistant cases changes the response entirely.
- Case-finding audit: has microscopy or Xpert access recently improved? That can inflate counts without true increase.
The clustering in one ward with crowded, poorly ventilated housing and household child contacts suggests ongoing household and community transmission, not random variation. Children under 5 in a household are a red flag for recent transmission and warrant active screening and preventive therapy assessment.
2. Design the immediate public health response, prioritizing what the district can actually do with its resources.
Read the worked answer
Priority actions, in order:
- Active case finding - screen all household and close contacts of the 14 cases; prioritize children under 5 and immunocompromised contacts.
- Confirm and characterize cases - use the limited Xpert cartridges on new and previously treated cases first, since rifampicin resistance changes management; microscopy for the rest.
- Treatment adherence - the report of default at 2 months is the single biggest driver of ongoing transmission and resistance. Strengthen DOTS with treatment supporters, SMS/phone follow-up, and tracing of defaulters; consider community-based DOTS.
- Infection control - counsel on ventilation (open windows, separate sleeping space), cough hygiene, and sunlight; this is low-cost and effective in crowded homes.
- Child contacts - evaluate for TB disease and offer isoniazid preventive therapy per national policy after excluding active disease; ensure BCG status.
- Health education - address stigma and the "feel better, stop early" pattern explicitly.
Do not launch a mass campaign before contact tracing is done; targeted action beats broad screening here.
3. What indicators would you monitor over the next 6 months to judge whether the response is working?
Read the worked answer
Process and outcome indicators:
- Case notification rate in the ward (and proportion smear/Xpert-positive) - falling notification with rising case-finding suggests control; rising notification with the same case-finding suggests failure.
- Treatment adherence: proportion completing treatment, default rate at 2 months, and proportion lost to follow-up.
- Contact tracing coverage: proportion of household contacts screened and proportion of eligible children started on preventive therapy.
- Drug resistance: proportion of new cases with rifampicin resistance on Xpert.
- Time to diagnosis and time to treatment start.
- Pediatric cases - a falling count in under-5s is an early signal of reduced transmission.
Set a review at 3 and 6 months; if default and contact tracing do not improve, escalate to the national program for support and consider broader active screening.